Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Goodwill & Intangibles (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Goodwill & Intangibles for 2 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 11.62% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, up 11.62% year-over-year, with the annual reading at $2.9 million for FY2025, 11.62% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $2.9 million at Pyxis Oncology, up from $2.4 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $23.7 million in Q1 2024, with the low at $2.4 million in Q3 2025.